home
“Paranova is playing an important part in stimulation competition in the pharmaceutical market.” Erik B. Pfeiffer
Company > About Paranova

A pioneer for more than 15 years

Paranova is a Danish company founded in 1989 by Erik B. Pfeiffer. In October 2010 Paranova and Germany’s MPA Pharma signed a cooperation agreement. MPA Pharma and its subsidiary EMRAmed have been leading reimporters and parallel importers of EU medical products in Germany for 30 years. The affiliation allows Paranova to offer Scandinavia’s pharmacies a far broader product range, better delivery capabilities and additional services.

We strongly believe that only through sound and transparent competition, patients and national health care systems will achieve the best treatment at affordable prices. Paranova has played an important part in stimulation competition in the pharmaceutical market and thus made the best treatment more affordable to patients. We will continue to strengthen our efforts.

 

The principle of the free movement of goods

Paranova is founded on one of the most important principles of the European Union: the principle of the free movement of goods. Paranova pioneered bringing parallel imported pharmaceuticals onto the Scandinavian markets for the first time. This was in late 1990.

Paranova Group A/S is the parent company of all the companies in the Group and employs a total of 40 employees. The Group consists of several subsidiaries including:
Paranova Danmark A/S
Paranova Läkemedel AB
Paranova OY
which are handling the sales and marketing activities in Denmark, Sweden and Finland.

Many years ago we introduced parallel imported pharmaceutical products in Denmark, Sweden and Finland where we are represented by our sales companies – today we are also represented in Germany by our holding company MPA Pharma www.mpapharma.com and its subsidiary EMRAmed www.emramed.de

Paranova has taken a leading role in championing the legal framework for parallel trade both at the European level and at the national level. The affiliation with MPA Pharma allows Paranova to offer Scandinavia’s pharmacies a far broader product range, better delivery capabilities and additional services. Paranova and MPA Pharma have become one of the leading parallel import companies in Europe.